Fresh analysis reveals that people who discontinue popular slimming jabs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who stop conventional lifestyle regimens.
Published data in a prominent health publication points out that while obese individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"People buying these drugs should be aware of the potential of fast rebound weight gain when the treatment concludes," stated lead investigator Dr. Susan Jebb.
Such speed of regain implies a reversion to original mass in about one and a half years.
Analyzing Treatments
The study, which examined 37 of studies involving thousands of patients, contrasted the results of the injectable medications with conventional dieting.
Scientists note that people who lose weight through lifestyle changes alone generally have a less rapid weight regain—approximately 0.1 kg a month—after stopping.
Explaining the Rapid Rebound
Nutrition scientists propose the mechanism of the drugs is key to understanding the heightened weight return.
These medications mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing the hormone concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement leads to hunger is no longer kept in check, making excessive eating a significant risk."
A Lifelong Condition?
The NHS suggest the jabs for people with obesity-related health risks, accompanied by recommended lifestyle changes.
Many experts argue that, considering the high risk of relapse, the therapy should be considered ongoing.
This view is reinforced by drug manufacturers, who say that the results "highlight the long-term character of obesity," similar to managing conditions like high blood pressure.
Patient Experiences
People who have discontinued the medication describe a intense return of cravings.
"It was like something activating and I was suddenly starving," said a patient.
This difficulty is compounded if patients have not established sustainable lifestyle or habit modifications during treatment.
Widespread Adoption
Figures indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with demand being substantial.
- Use is more common among women compared to males.
- The middle-aged age group shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while these medications are powerful agents for weight loss, they are not a permanent solution and lasting health benefits likely depends on ongoing lifestyle changes.
